FAW Jiefang(SZ:000800) Xin Lang Cai Jing·2025-11-28 00:37Market Overview - On November 27, 2025, A-shares showed mixed performance with the Shanghai Composite Index closing at 3875.26 points, up 0.29%, while the Shenzhen Component Index fell 0.25% to 12875.19 points, and the ChiNext Index decreased by 0.44% to 3031.30 points. Over 2700 stocks rose in value, with total trading volume in the Shanghai and Shenzhen markets at 1.71 trillion yuan, a decrease of 70 billion yuan from the previous trading day [1] - Hong Kong stocks experienced fluctuations, with the Hang Seng Index closing up 0.07% at 25945.93 points and a total trading volume of 204.73 billion HKD. The Hang Seng China Enterprises Index rose 0.03%, while the Hang Seng Tech Index fell 0.36% [1] - U.S. stock markets were closed on November 27 due to the Thanksgiving holiday, with early market closure expected on November 28 [1] New Stock Subscription - The new stock available for subscription is Bai'ao Saitou, listed on the Sci-Tech Innovation Board with a stock code of 688796. The issue price is 26.68 yuan per share, with a price-to-earnings ratio of 519.12 times. The company focuses on gene editing technology and aims to become a global source of new drugs, providing innovative animal models and preclinical drug development services [3] Regulatory News - The State Administration for Market Regulation held its fifth enterprise fair competition symposium on November 27, 2025, discussing the promotion of fair competition and optimization of the business environment. Key foreign enterprises such as Samsung, BMW, Johnson & Johnson, and Bayer participated in the discussions [4] - The administration emphasized strengthening antitrust enforcement in key areas, enhancing fair competition reviews, and addressing barriers to the construction of a unified national market to create a market-oriented, law-based, and international business environment [5] - The National Development and Reform Commission highlighted the rapid growth of the humanoid robot industry, which is expected to exceed a market scale of 100 billion yuan by 2030, growing at over 50% annually. However, it cautioned against the risk of oversaturation in the market with similar products and the potential compression of R&D space due to the influx of over 150 humanoid robot companies, many of which are startups [5]